Category: Regulations
-
Flashback: Drug Pricing Reform Even Big Pharma Might Like
Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October. 2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription drug prices,…
-
Trial Comparing 2-D, 3-D Mammogram Outcomes
A large-scale clinical trial is underway comparing the effectiveness of two-dimensional and three-dimensional mammograms in screening for breast cancer.
-
Guidelines Designed for CAR T-Cell Cancer Therapies
Cancer specialists and scientists at several cancer care centers propose safety guidelines for patients receiving engineered immune cell treatments that often have severe adverse effects.
-
FDA Clears First Mobile App for Substance Abuse
A smartphone app designed to help treat substance abuse disorders received approval from the U.S. Food and Drug Administration.
-
Trial Shows Antibody Effective Against Asthma
Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning.
-
Risks of E-Cigarette Use, Ingredients Highlighted
Several sessions at a scientific meeting on respiratory diseases report on effects of electronic cigarettes on people’s health, including those who also smoke conventional cigarettes.
-
Engineered T-Cell Trials Stopped after Patient Death
The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died.
-
Trial Testing Nicotine Patch for Lung Inflammation
A clinical trial is underway testing a nicotine patch worn to help stop smoking as a treatment for a chronic inflammatory disease affecting the lungs.
-
Infographic – Vaccinations Changed the World
This chart, courtesy of Der Spiegel and Statista, shows how the incidence of several diseases has been reduced in the U.S. since the introduction of vaccines.
-
Telemedicine Shown Feasible for Parkinson’s Care
Findings from a one-year clinical trial show individuals in the U.S. with Parkinson’s disease can receive quality care through telemedicine comparable to persons with the disorder receiving the usual care from neurologists alone.